Structural Heart Disease Treatment Devices Professional Market 2028 By Product, End-user and Geography | The Insight Partners

report image

Structural Heart Disease Treatment Devices Professional Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Replacement devices, Repair devices); End-user (Hospitals and clinics, ASCs) and Geography

Report Code: TIPRE00024859 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

MARKET OVERVIEW

Structural heart disease refers to a problem with the tissues or valves of the heart. Many structural heart conditions could be witnessed since birth, but some may develop later in life because of wear and tear from infection. There are various kinds of structural heart diseases such as aortic valve stenosis, heart valve disease, left ventricular hypertrophy, myocarditis, mitral valve regurgitation, and many more. Various symptoms differ depending upon the condition and the patient. Although, general symptoms include shortness of breath, chest pain, high blood pressure, and mini-strokes.

MARKET SCOPE

The "Global Structural Heart Disease Treatment Devices Professional Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the structural heart disease treatment devices professional market with detailed market segmentation by product, end user, and geography. The report provides key statistics on the market status of the leading structural heart disease treatment devices professional market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on product, the global structural heart disease treatment devices professional market is segmented into replacement devices and repair devices.
  •  On the basis of end-users, the market is bifurcated into hospitals and clinics, ASCs.

MARKET DYNAMICS
Drivers:

  •  Increase in the prevalence of structural heart diseases such as congenital heart defects, aortic stenosis, and heart valve disease.
  •  Rise in the number of innovative product launches.
  •  Technological advancement in structural heart disease treatment.
  •  Increase in the number of M&A activities.
  •  Strong clinical pipeline for heart valve devices.

Restraints:

  •  The high price associated with structural heart disease treatment procedures
  •  Lack of skilled personnel.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The structural heart disease treatment devices professional market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the structural heart disease treatment devices professional market in these regions.

IMPACT OF COVID-19 ON STRUCTURAL HEART DISEASE TREATMENT DEVICES PROFESSIONAL MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The pandemic outbreak had significantly slowed down the growth of the market due to worldwide lockdown. The treatment of various diseases was delayed as the appointments were postponed and canceled. All the focus was shifted towards COVID-19 patients, affecting the market growth. Moreover, the outbreak has also disrupted the supply chain, restricted trade, thereby affecting the business and caused less demand for the product impacting the market growth. However, the market will experience growth after the removal of restrictive measures and companies resuming their operations and adapting to the new normal.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the structural heart disease treatment devices professional market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from structural heart disease treatment devices professional market are anticipated to have lucrative growth opportunities in the future with the rising demand for structural heart disease treatment devices professional in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the structural heart disease treatment devices professional market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Abbott Laboratories
  •  Becton,Dickinson and Co.
  •  Braile Biomedica
  •  Boston Scientific Corp.
  •  CryoLife Inc.
  •  Edwards Lifesciences Corp.
  •  LivaNova Plc
  •  Lepu Medical Technology (Beijing) Co. Ltd.
  •  Medtronic Plc
  •  MicroPort Scientific Corp.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

The List of Companies

1. Abbott Laboratories
2. Becton, Dickinson and Co.
3. Braile Biomedica
4. Boston Scientific Corp.
5. CryoLife Inc.
6. Edwards Lifesciences Corp.
7. LivaNova Plc
8. Lepu Medical Technology (Beijing) Co. Ltd.
9. Medtronic Plc
10. MicroPort Scientific Corp.
TIPRE00024859
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount